FDA Inspection 1226721 — Noel M. Varghese, M.B.B.S
The FDA completed an inspection of Noel M. Varghese, M.B.B.S on Dec 15, 2023 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Singapore (Singapore)
Additional details
Clinical BA/BE